Companion Diagnostic Technologies Market 2027 By Technology, Indication, End User and Geography | The Insight Partners

Companion Diagnostic Technologies Market to 2027 - Global Analysis and Forecasts By Technology (PCR, IHC, NGS, ISH); Indication (Breast cancer, NSCLC, Colorectal Cancer, Neurological Disorders, Infectious Diseases); End User (Pharmaceutical and Biopharmaceutical Companies, Reference Lab) and Geography

Report Code: TIPRE00004732 | No. of Pages: 150 | Category: Medical Device | Status: Upcoming
MARKET INTRODUCTION
A companion diagnostic technologies are some of the tests which are performed to get an information of safety and effectives of corresponding drug or biological product. This test helps a doctor to determine whether a particular therapeutics products benefits the patient or having causes any side effects as well as it help to select patient treatment.

MARKET DYNAMICS
The companion diagnostic technologies market is expected to grow during the forecast period owing to the key driving factors such as rising male geriatric population, awareness related to urological disorder and prostate cancer and others. In addition, various players in the emerging market have strong pipeline product and high potential which are anticipated to create several growth opportunities for the market during the forecast period.

MARKET SCOPE
The "Global Companion Diagnostic Technologies Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of companion diagnostic technologies with detailed market segmentation by technology, Indication, end user and geography. The global companion diagnostic technologies is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading the companion diagnostic technologies players and offers key trends and opportunities in the market.

MARKET SEGMENTATION
The global companion diagnostic technologies market is segmented on the basis of technology, Indication, end user and therapy. Based on technology, the market is segmented as PCR, IHC, NGS, and ISH. On the basis of Indication, the global companion diagnostic technologies market is segmented Breast cancer, NSCLC, colorectal cancer, neurological disorders, and infectious diseases. Based on the end user the market is classify into pharmaceutical & biopharmaceutical companies and reference lab.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global companion diagnostic technologies market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Companion Diagnostic Technologies market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting companion diagnostic technologies market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Companion Diagnostic Technologies market in these regions.

MARKET PLAYERS
The reports cover key developments in the Companion Diagnostic Technologies market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Companion Diagnostic Technologies market are anticipated to lucrative growth opportunities in the future with the rising demand for Companion Diagnostic Technologies in the global market. Below mentioned is the list of few companies engaged in the Companion Diagnostic Technologies market.

The report also includes the profiles of key Companion Diagnostic Technologies market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
  • BioSpace
  • QIAGEN
  • F. Hoffmann-La Roche Ltd
  • Abbott
  • bioMerieux SA
  • Myriad Genetics, Inc.
  • BioGenex
  • Thermo Fisher Scientific Inc
  • Leica Biosystems Nussloch GmbH
Dako Inc
The Insight Partner's dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Companion Diagnostic Technologies Market - By Technology
1.3.2 Companion Diagnostic Technologies Market - By Indication
1.3.3 Companion Diagnostic Technologies Market - By End User
1.3.4 Companion Diagnostic Technologies Market - By Region
1.3.4.1 By Country
2. KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
4. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS
6. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - GLOBAL MARKET ANALYSIS
6.1. COMPANION DIAGNOSTIC TECHNOLOGIES - GLOBAL MARKET OVERVIEW
6.2. COMPANION DIAGNOSTIC TECHNOLOGIES - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - TECHNOLOGY
7.1. OVERVIEW
7.2. TECHNOLOGY MARKET FORECASTS AND ANALYSIS
7.3. PCR
7.3.1. Overview
7.3.2. PCR Market Forecast and Analysis
7.4. IHC
7.4.1. Overview
7.4.2. IHC Market Forecast and Analysis
7.5. NGS
7.5.1. Overview
7.5.2. NGS Market Forecast and Analysis
7.6. ISH
7.6.1. Overview
7.6.2. ISH Market Forecast and Analysis
8. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - INDICATION
8.1. OVERVIEW
8.2. INDICATION MARKET FORECASTS AND ANALYSIS
8.3. BREAST CANCER
8.3.1. Overview
8.3.2. Breast cancer Market Forecast and Analysis
8.4. NSCLC
8.4.1. Overview
8.4.2. NSCLC Market Forecast and Analysis
8.5. COLORECTAL CANCER
8.5.1. Overview
8.5.2. Colorectal cancer Market Forecast and Analysis
8.6. NEUROLOGICAL DISORDERS
8.6.1. Overview
8.6.2. Neurological disorders Market Forecast and Analysis
8.7. INFECTIOUS DISEASES
8.7.1. Overview
8.7.2. Infectious Diseases Market Forecast and Analysis
9. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET - REVENUE AND FORECASTS TO 2027 - END USER
9.1. OVERVIEW
9.2. END USER MARKET FORECASTS AND ANALYSIS
9.3. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
9.3.1. Overview
9.3.2. Pharmaceutical and Biopharmaceutical Companies Market Forecast and Analysis
9.4. REFERENCE LAB
9.4.1. Overview
9.4.2. Reference Lab Market Forecast and Analysis
10. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
10.1. NORTH AMERICA
10.1.1 North America Companion Diagnostic Technologies Market Overview
10.1.2 North America Companion Diagnostic Technologies Market Forecasts and Analysis
10.1.3 North America Companion Diagnostic Technologies Market Forecasts and Analysis - By Technology
10.1.4 North America Companion Diagnostic Technologies Market Forecasts and Analysis - By Indication
10.1.5 North America Companion Diagnostic Technologies Market Forecasts and Analysis - By End User
10.1.6 North America Companion Diagnostic Technologies Market Forecasts and Analysis - By Countries
10.1.6.1 United States Companion Diagnostic Technologies Market
10.1.6.1.1 United States Companion Diagnostic Technologies Market by Technology
10.1.6.1.2 United States Companion Diagnostic Technologies Market by Indication
10.1.6.1.3 United States Companion Diagnostic Technologies Market by End User
10.1.6.2 Canada Companion Diagnostic Technologies Market
10.1.6.2.1 Canada Companion Diagnostic Technologies Market by Technology
10.1.6.2.2 Canada Companion Diagnostic Technologies Market by Indication
10.1.6.2.3 Canada Companion Diagnostic Technologies Market by End User
10.1.6.3 Mexico Companion Diagnostic Technologies Market
10.1.6.3.1 Mexico Companion Diagnostic Technologies Market by Technology
10.1.6.3.2 Mexico Companion Diagnostic Technologies Market by Indication
10.1.6.3.3 Mexico Companion Diagnostic Technologies Market by End User
10.2. EUROPE
10.2.1 Europe Companion Diagnostic Technologies Market Overview
10.2.2 Europe Companion Diagnostic Technologies Market Forecasts and Analysis
10.2.3 Europe Companion Diagnostic Technologies Market Forecasts and Analysis - By Technology
10.2.4 Europe Companion Diagnostic Technologies Market Forecasts and Analysis - By Indication
10.2.5 Europe Companion Diagnostic Technologies Market Forecasts and Analysis - By End User
10.2.6 Europe Companion Diagnostic Technologies Market Forecasts and Analysis - By Countries
10.2.6.1 Germany Companion Diagnostic Technologies Market
10.2.6.1.1 Germany Companion Diagnostic Technologies Market by Technology
10.2.6.1.2 Germany Companion Diagnostic Technologies Market by Indication
10.2.6.1.3 Germany Companion Diagnostic Technologies Market by End User
10.2.6.2 France Companion Diagnostic Technologies Market
10.2.6.2.1 France Companion Diagnostic Technologies Market by Technology
10.2.6.2.2 France Companion Diagnostic Technologies Market by Indication
10.2.6.2.3 France Companion Diagnostic Technologies Market by End User
10.2.6.3 Italy Companion Diagnostic Technologies Market
10.2.6.3.1 Italy Companion Diagnostic Technologies Market by Technology
10.2.6.3.2 Italy Companion Diagnostic Technologies Market by Indication
10.2.6.3.3 Italy Companion Diagnostic Technologies Market by End User
10.2.6.4 Spain Companion Diagnostic Technologies Market
10.2.6.4.1 Spain Companion Diagnostic Technologies Market by Technology
10.2.6.4.2 Spain Companion Diagnostic Technologies Market by Indication
10.2.6.4.3 Spain Companion Diagnostic Technologies Market by End User
10.2.6.5 United Kingdom Companion Diagnostic Technologies Market
10.2.6.5.1 United Kingdom Companion Diagnostic Technologies Market by Technology
10.2.6.5.2 United Kingdom Companion Diagnostic Technologies Market by Indication
10.2.6.5.3 United Kingdom Companion Diagnostic Technologies Market by End User
10.3. ASIA-PACIFIC
10.3.1 Asia-Pacific Companion Diagnostic Technologies Market Overview
10.3.2 Asia-Pacific Companion Diagnostic Technologies Market Forecasts and Analysis
10.3.3 Asia-Pacific Companion Diagnostic Technologies Market Forecasts and Analysis - By Technology
10.3.4 Asia-Pacific Companion Diagnostic Technologies Market Forecasts and Analysis - By Indication
10.3.5 Asia-Pacific Companion Diagnostic Technologies Market Forecasts and Analysis - By End User
10.3.6 Asia-Pacific Companion Diagnostic Technologies Market Forecasts and Analysis - By Countries
10.3.6.1 Australia Companion Diagnostic Technologies Market
10.3.6.1.1 Australia Companion Diagnostic Technologies Market by Technology
10.3.6.1.2 Australia Companion Diagnostic Technologies Market by Indication
10.3.6.1.3 Australia Companion Diagnostic Technologies Market by End User
10.3.6.2 China Companion Diagnostic Technologies Market
10.3.6.2.1 China Companion Diagnostic Technologies Market by Technology
10.3.6.2.2 China Companion Diagnostic Technologies Market by Indication
10.3.6.2.3 China Companion Diagnostic Technologies Market by End User
10.3.6.3 India Companion Diagnostic Technologies Market
10.3.6.3.1 India Companion Diagnostic Technologies Market by Technology
10.3.6.3.2 India Companion Diagnostic Technologies Market by Indication
10.3.6.3.3 India Companion Diagnostic Technologies Market by End User
10.3.6.4 Japan Companion Diagnostic Technologies Market
10.3.6.4.1 Japan Companion Diagnostic Technologies Market by Technology
10.3.6.4.2 Japan Companion Diagnostic Technologies Market by Indication
10.3.6.4.3 Japan Companion Diagnostic Technologies Market by End User
10.3.6.5 South Korea Companion Diagnostic Technologies Market
10.3.6.5.1 South Korea Companion Diagnostic Technologies Market by Technology
10.3.6.5.2 South Korea Companion Diagnostic Technologies Market by Indication
10.3.6.5.3 South Korea Companion Diagnostic Technologies Market by End User
10.4. MIDDLE EAST AND AFRICA
10.4.1 Middle East and Africa Companion Diagnostic Technologies Market Overview
10.4.2 Middle East and Africa Companion Diagnostic Technologies Market Forecasts and Analysis
10.4.3 Middle East and Africa Companion Diagnostic Technologies Market Forecasts and Analysis - By Technology
10.4.4 Middle East and Africa Companion Diagnostic Technologies Market Forecasts and Analysis - By Indication
10.4.5 Middle East and Africa Companion Diagnostic Technologies Market Forecasts and Analysis - By End User
10.4.6 Middle East and Africa Companion Diagnostic Technologies Market Forecasts and Analysis - By Countries
10.4.6.1 South Africa Companion Diagnostic Technologies Market
10.4.6.1.1 South Africa Companion Diagnostic Technologies Market by Technology
10.4.6.1.2 South Africa Companion Diagnostic Technologies Market by Indication
10.4.6.1.3 South Africa Companion Diagnostic Technologies Market by End User
10.4.6.2 Saudi Arabia Companion Diagnostic Technologies Market
10.4.6.2.1 Saudi Arabia Companion Diagnostic Technologies Market by Technology
10.4.6.2.2 Saudi Arabia Companion Diagnostic Technologies Market by Indication
10.4.6.2.3 Saudi Arabia Companion Diagnostic Technologies Market by End User
10.4.6.3 U.A.E Companion Diagnostic Technologies Market
10.4.6.3.1 U.A.E Companion Diagnostic Technologies Market by Technology
10.4.6.3.2 U.A.E Companion Diagnostic Technologies Market by Indication
10.4.6.3.3 U.A.E Companion Diagnostic Technologies Market by End User
10.5. SOUTH AND CENTRAL AMERICA
10.5.1 South and Central America Companion Diagnostic Technologies Market Overview
10.5.2 South and Central America Companion Diagnostic Technologies Market Forecasts and Analysis
10.5.3 South and Central America Companion Diagnostic Technologies Market Forecasts and Analysis - By Technology
10.5.4 South and Central America Companion Diagnostic Technologies Market Forecasts and Analysis - By Indication
10.5.5 South and Central America Companion Diagnostic Technologies Market Forecasts and Analysis - By End User
10.5.6 South and Central America Companion Diagnostic Technologies Market Forecasts and Analysis - By Countries
10.5.6.1 Brazil Companion Diagnostic Technologies Market
10.5.6.1.1 Brazil Companion Diagnostic Technologies Market by Technology
10.5.6.1.2 Brazil Companion Diagnostic Technologies Market by Indication
10.5.6.1.3 Brazil Companion Diagnostic Technologies Market by End User
10.5.6.2 Argentina Companion Diagnostic Technologies Market
10.5.6.2.1 Argentina Companion Diagnostic Technologies Market by Technology
10.5.6.2.2 Argentina Companion Diagnostic Technologies Market by Indication
10.5.6.2.3 Argentina Companion Diagnostic Technologies Market by End User
11. INDUSTRY LANDSCAPE
11.1. MERGERS AND ACQUISITIONS
11.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
11.3. NEW PRODUCT LAUNCHES
11.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
12. COMPANION DIAGNOSTIC TECHNOLOGIES MARKET, KEY COMPANY PROFILES
12.1. BIOSPACE
12.1.1. Key Facts
12.1.2. Business Description
12.1.3. Products and Services
12.1.4. Financial Overview
12.1.5. SWOT Analysis
12.1.6. Key Developments
12.2. QIAGEN
12.2.1. Key Facts
12.2.2. Business Description
12.2.3. Products and Services
12.2.4. Financial Overview
12.2.5. SWOT Analysis
12.2.6. Key Developments
12.3. F. HOFFMANN-LA ROCHE LTD
12.3.1. Key Facts
12.3.2. Business Description
12.3.3. Products and Services
12.3.4. Financial Overview
12.3.5. SWOT Analysis
12.3.6. Key Developments
12.4. ABBOTT
12.4.1. Key Facts
12.4.2. Business Description
12.4.3. Products and Services
12.4.4. Financial Overview
12.4.5. SWOT Analysis
12.4.6. Key Developments
12.5. BIOMéRIEUX SA
12.5.1. Key Facts
12.5.2. Business Description
12.5.3. Products and Services
12.5.4. Financial Overview
12.5.5. SWOT Analysis
12.5.6. Key Developments
12.6. MYRIAD GENETICS, INC.
12.6.1. Key Facts
12.6.2. Business Description
12.6.3. Products and Services
12.6.4. Financial Overview
12.6.5. SWOT Analysis
12.6.6. Key Developments
12.7. BIOGENEX
12.7.1. Key Facts
12.7.2. Business Description
12.7.3. Products and Services
12.7.4. Financial Overview
12.7.5. SWOT Analysis
12.7.6. Key Developments
12.8. THERMO FISHER SCIENTIFIC INC.
12.8.1. Key Facts
12.8.2. Business Description
12.8.3. Products and Services
12.8.4. Financial Overview
12.8.5. SWOT Analysis
12.8.6. Key Developments
12.9. LEICA BIOSYSTEMS NUSSLOCH GMBH
12.9.1. Key Facts
12.9.2. Business Description
12.9.3. Products and Services
12.9.4. Financial Overview
12.9.5. SWOT Analysis
12.9.6. Key Developments
12.10. DAKO INC
12.10.1. Key Facts
12.10.2. Business Description
12.10.3. Products and Services
12.10.4. Financial Overview
12.10.5. SWOT Analysis
12.10.6. Key Developments
13. APPENDIX
13.1. ABOUT THE INSIGHT PARTNERS
13.2. GLOSSARY OF TERMS
The List of Companies

1. BioSpace
2. QIAGEN
3. F. Hoffmann-La Roche Ltd
4. Abbott
5. bioMerieux SA
6. Myriad Genetics, Inc.
7. BioGenex
8. Thermo Fisher Scientific Inc.
9. Leica Biosystems Nussloch GmbH
10. Dako Inc.